Q32 Bio Inc. (QTTB) financial statements and ratios from SEC XBRL: revenue $53.74M (TTM), net margin 55.5%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $53.74M |
| Net Margin | 55.5% |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 162.6% |
| FCF Growth (YoY) | -29.7% |
| Price / Book | 5.85 |
| FCF Yield | -18.6% |
| Altman Z-Score | 5.07 (safe) |
| Sector P/E (Healthcare) | 21.7 |
QTTB overview · QTTB earnings · QTTB KPIs · QTTB investor relations · QTTB ownership · QTTB peers · QTTB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.